NCT01522183 · Observational
Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
Atypical Hemolytic-Uremic Syndrome
Study overall: Recruiting · source record updated 16 September 2025.
8 England locations · 7 explicitly recorded as recruiting.
RESEARCH IN ENGLAND
Explore clinical trials with England locations
Search 2,970 registered studies with identifiable England locations in our dated ClinicalTrials.gov snapshot. Explore the study and local recruitment details before contacting the research team.
159 matching studies · ordered by study identifier.
The area filter uses exact source postcodes. Locations without a matched postcode remain in the England-wide results.
NCT01574053 · Observational
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Huntington's Disease
Study overall: Recruiting · source record updated 28 February 2024.
21 England locations · 19 explicitly recorded as recruiting.
NCT01804686 · Interventional
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma · Mantle Cell Lymphoma · Follicular Lymphoma · Diffuse Large B-cell Lymphoma · Waldenstrom Macroglobulinemia · Chronic Graft Versus Host Disease
Study overall: Recruiting · source record updated 31 July 2026.
15 England locations · 2 explicitly recorded as recruiting.
NCT02735707 · Interventional
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Community-acquired Pneumonia, Influenza, COVID-19
Study overall: Recruiting · source record updated 12 July 2024.
131 England locations · 54 explicitly recorded as recruiting.
NCT03150576 · Interventional
Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer
Breast Cancer
Study overall: Recruiting · source record updated 14 November 2022.
26 England locations · 26 explicitly recorded as recruiting.
NCT03193476 · Observational
Registry for Patients With X-Linked Hypophosphatemia
X-Linked Hypophosphatemia
Study overall: Recruiting · source record updated 9 July 2026.
15 England locations · 0 explicitly recorded as recruiting.
NCT03435796 · Interventional
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Neoplasms
Study overall: Recruiting · source record updated 4 September 2026.
5 England locations · 4 explicitly recorded as recruiting.
NCT03813407 · Interventional
An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia
Hyperkalaemia
Study overall: Recruiting · source record updated 13 August 2026.
3 England locations · 1 explicitly recorded as recruiting.
NCT03899155 · Interventional
Pan Tumor Rollover Study
Cancer
Study overall: Recruiting · source record updated 29 July 2026.
8 England locations · 1 explicitly recorded as recruiting.
NCT03969329 · Interventional
A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis
Secondary Hyperparathyroidism
Study overall: Recruiting · source record updated 21 August 2026.
3 England locations · 2 explicitly recorded as recruiting.
NCT04006808 · Interventional
A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant
Herpes Zoster
Study overall: Recruiting · source record updated 27 February 2026.
5 England locations · 4 explicitly recorded as recruiting.
NCT04050345 · Observational
Tracking Mutations in Cell Free Tumour DNA to Predict Relapse in Early Colorectal Cancer
Colorectal Cancer
Study overall: Recruiting · source record updated 14 June 2024.
62 England locations · 57 explicitly recorded as recruiting.
NCT04068597 · Interventional
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Haematological Malignancy · Acute Myeloid Leukemia · Non Hodgkin Lymphoma · Multiple Myeloma · Higher-risk Myelodysplastic Syndrome · Peripheral T Cell Lymphoma
Study overall: Recruiting · source record updated 24 June 2026.
15 England locations · 15 explicitly recorded as recruiting.
NCT04103372 · Interventional
Pre-therapeutic MRI Assessment of Early-Stage Rectal Cancer and Significant Rectal Polyps to Avoid Major Resectional Surgery
Rectal Cancer · Colo-rectal Cancer
Study overall: Recruiting · source record updated 4 November 2024.
22 England locations · 1 explicitly recorded as recruiting.
NCT04104776 · Interventional
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Advanced Solid Tumor · Diffuse Large B Cell Lymphoma · Lymphoma, T-Cell · Mesothelioma, Malignant · Prostatic Neoplasms, Castration-Resistant · Endometrial Cancer · Ovarian Clear Cell Carcinoma · Metastatic Castration-resistant Prostate Cancer
Study overall: Recruiting · source record updated 19 August 2026.
9 England locations · 1 explicitly recorded as recruiting.
NCT04116502 · Interventional
MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera
Polycythemia Vera
Study overall: Recruiting · source record updated 28 April 2026.
40 England locations · 38 explicitly recorded as recruiting.
NCT04165486 · Interventional
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ION464 Administered to Adults With Multiple System Atrophy (HORIZON)
Multiple System Atrophy
Study overall: Recruiting · source record updated 27 April 2026.
4 England locations · 4 explicitly recorded as recruiting.
NCT04204915 · Interventional
The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study
Aortic Stenosis
Study overall: Recruiting · source record updated 21 July 2026.
66 England locations · 63 explicitly recorded as recruiting.
NCT04253015 · Observational
A Post-Authorisation Safety Study Patient Registry of Patients With Neuroblastoma Being Treated With Dinutuximab Beta
Neuroblastoma
Study overall: Recruiting · source record updated 7 February 2024.
3 England locations · 2 explicitly recorded as recruiting.
NCT04256317 · Interventional
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Myelodysplastic Syndromes · Acute Myeloid Leukemia · Myelodysplastic Syndrome/Neoplasm · Chronic Myelomonocytic Leukemia
Study overall: Recruiting · source record updated 30 April 2026.
3 England locations · 2 explicitly recorded as recruiting.
More ways to explore research
This is a selected international registry feed, not every study taking place in England. NIHR also lists participation opportunities, including studies that may not appear in this selection.
Source: ClinicalTrials.gov, a United States Government database. Contains OS data © Crown copyright and database right 2026. Contains National Statistics data © Crown copyright and database right 2024; ONS country boundaries (December 2024).
Source processed: 2026-09-10 09:00:04 UTC. Retrieved: 10 September 2026. ClinicalTrials.gov terms.
How we selected and connected these records
Selected registered studies with an overall status of Recruiting or Not yet recruiting and at least one England location established by postcode, recorded nation, or source coordinates within the ONS December 2024 boundary. Retained structured fields; omitted descriptions, eligibility text, contacts and non-England locations. Deduplicated identical locations. Linked local care areas only by exact postcode geography. Location points are used for nation filtering, not directions or facility matching.